Scholarly Index
Sung Soo Ahn
Hanwha Techwin (South Korea); 1,826 total citations; 187 total publications; best world rank #28
Hanwha Techwin (South Korea)
1,826Total citations
187Total publications
23H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Vasculitis and related conditions | Lifetime | 653 | KR 10 | 94.60 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 328 | KR 6 | 91.78 |
| Whipple's Disease and Interleukins | Lifetime | 707 | KR 4 | 58.14 |
| Vasculitis and related conditions | 2021-2025 | 76 | KR 2 | 97.29 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 94 | KR 2 | 95.00 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 342 | KR 4 | 93.92 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 98 | KR 3 | 88.54 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 244 | KR 8 | 88.55 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 720 | KR 29 | 90.29 |
| Urticaria and Related Conditions | 2021-2025 | 378 | KR 6 | 87.54 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 564 | KR 5 | 82.19 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 734 | KR 6 | 77.58 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 266 | KR 1 | 77.16 |
| Whipple's Disease and Interleukins | 2021-2025 | 28 | KR 1 | 70.97 |